Why BGPT?
logo

Check Claims Before You Publish

See how your reported results read as versioned evidence records β€” linked to experiments and limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to review claims



    Explore by Goal












     Quick Explanation


    Hui Yuan β€” scientific strength (evidence-based)
    Your provided bibliometrics show h-index = 4, 52 total citations, and 7 papers (as supplied). Across the specific full-text-derived research items you included (e.g., ), the work appears to emphasize mechanistic biological validation (not just correlation), but several items also carry scope/translation limitations (strain limits, model limits, sample sizes) that are typical but must be weighed skeptically.



     Long Explanation


    BGPT Author Review β€” Hui Yuan
    Date context: March 21, 2026 (user-provided). This review is constrained to the information you supplied (bibliometrics + the included full-text-derived research extracts with DOIs/values).
    1) Provided citation metrics (from your data)
    • h-index: 4
    • Total citations: 52
    • Paper count: 7
    • Affiliations: (blank in provided data)
    2) Evidence-grounded scientific content shown in your raw full-text extracts
    The strongest β€œscience-grade” signal in your supplied raw extracts comes from a clear end-to-end experimental story in bacterial antimicrobial resistance and metabolism: metabolomics β†’ mechanistic intermediates (pyruvate cycle, NADH, PMF) β†’ uptake/permeability measurements β†’ genetic perturbations β†’ in vivo survival outcomes. Example: the aspartate–tobramycin potentiation study is summarized in the extract you provided for .
    2A) Visuals β€” aspartate + tobramycin (MDR Edwardsiella tarda) extract metrics
    Note: the following figures reproduce only the numeric values explicitly present in your extract (no additional inference).
    Extract linkage for all three plots:
    3) Scientific quality appraisal (critical, evidence-weighted)
    Strengths (based on the type of evidence shown in your extracts)
    • Mechanism-oriented design: the aspartate–tobramycin work explicitly connects metabolite shifts to ATP/NADH/PMF and uptake/permeability, then validates with functional/perturbation tests (e.g., PMF collapse and genetic panels in the extract).
    • Multi-level validation: your extract includes metabolomics (GC–MS), microbiological susceptibility/killing, intracellular drug quantification, and in vivo survival outcomes in tilapia and mice.
    Limitations / possible blind spots (explicitly stated in your extracts)
    • Universality limits: the extract notes at least one MDR strain (A918) remains resistant, and optimal aspartate/tobramycin conditions differ between lab-evolved vs clinical isolatesβ€”both weaken a β€œsingle recipe fits all” claim.
    • Host translation uncertainty: in vivo models (tilapia and mice) may not fully recapitulate human infection biology.
    • Correlation vs causality risk in omics: the extract flags metabolomics as potentially correlative, not fully causal in all strains.
    Skeptical check: what would most likely disprove the mechanistic story?
    Your extract already provides falsification angles (e.g., failure to increase intracellular tobramycin under conditions expected to boost PMF; CCCP independence; no survival benefit across a diverse strain panel including the exception).
    4) Overall judgment on β€œHui Yuan” scientific strength (based only on your provided data)
    • Bibliometrics: h-index 4 and 52 total citations suggest a relatively modest footprint so far (as provided).
    • Evidence type: at least one supplied full-text-derived example shows strong mechanistic integration of multi-omic and functional assays plus in vivo validation (ASP+TOB study), which is a positive indicator for scientific rigor and biological reasoning.
    • But: your input does not clearly map β€œHui Yuan” to each supplied DOI extract; therefore, any credit assignment to the author for these specific findings would be a mapping assumption that I cannot make responsibly from your provided data.
    Confidence: moderate for the general assessment of the scientific style suggested by the full-text extracts; low-to-moderate for attributing those findings directly to Hui Yuan without explicit author–paper linkage.
    Why the Run button: your prompt includes many DOI extracts, but it does not explicitly tie each DOI to β€œHui Yuan.” The agent can iteratively verify mapping (if enough identifiers are present), extract additional quantitative endpoints, and perform mechanistic consistency checks.


    Feedback:    

    Updated: March 21, 2026

     BGPT Author Review


    Scientific Quality

    50%

    Based on your provided data, Hui Yuan’s bibliometrics (h-index 4; 52 citations; 7 papers) suggest an early-stage or lower-impact publication footprint. However, at least one supplied full-text-derived bacterial AMR example shows mechanistic integration (metabolomics β†’ NADH/PMF/membrane permeability β†’ uptake β†’ genetic perturbations β†’ in vivo survival), which is a hallmark of biological rigor. A major limitation is that your input does not clearly map each provided DOI extract to Hui Yuan, so direct attribution is uncertain; this reduces confidence in scoring scientific quality attributable specifically to the author.


    Communication Quality

    60%

    No direct writing samples from Hui Yuan were provided. The only communication signal is the structure of the supplied extracts (problem statement, methods, results, limitations). Those summaries are fairly structured and include limitations, which supports a moderate communication score, but it cannot be judged as the author’s actual prose.


    Author Novelty

    50%

    Novelty is inferred only from the themes of the supplied extracts (mechanism-driven adjuvant metabolite strategy; multi-omic integration frameworks; etc.), but without explicit mapping to Hui Yuan’s publications, novelty attributable to the author is uncertain. The available bibliometrics do not indicate a highly disruptive impact yet.


    Scientific Rigor

    50%

    Rigor appears moderate-to-strong in the supplied end-to-end extract example (multi-level validation and explicit limitations). Still, the author-specific rigor is not provable from your input because mapping between Hui Yuan and those specific DOIs is not explicit, and only one numeric dataset was clearly available for visualization.

     Top Data Sources ExportMCP


     Hypothesis Graveyard


    β€œAspartate universally potentiates all MDR aminoglycoside resistance mechanisms via a single PMF mechanism.” This is weakened by explicit exception-strain resistance in the extract.


    β€œSTING pathway activation alone is sufficient for durable abscopal tumor regression irrespective of vector design.” This is weakened by extract limitations emphasizing the need for mechanistic disentangling (e.g., GM-CSF vs cGAS effects) and model-dependent abscopal observations.

     Science Art


    Author Review: Hui Yuan Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending